ABSTRACT. Antibiotic beads have become popular for the treatment of local bacterial infections. The preparation of antibiotic beads from commercial pharmaceutical antibiotics is a convenient method in clinic. The elution characteristics of cefazolin from polymethylmethacrylate (PMMA) (SmartSet HV, Depuy I and Cemfix 3) beads and calcium sulfate beads were studied. Commercial cefazolin formulation was incorporated in PMMA or calcium sulfate at 1 g cefazolin /10 g of matrix substances to form beads. The concentrations of eluted cefazolin during 15 days were greater than MIC for Staphylococcus aureus (ATCC 25923). The eluted cefazolin concentrations were in the range of 3.6  1.2 to 4.6  0.4 mg for PMMA beads and 15.4  1.7 mg for calcium sulfate beads. The accumulated eluted cefazolin from PMMA beads and calcium sulfate beads for 15 days were 34.41  3.93 to 38.67  3.04% and 95.94  3.93%, respectively. The various storage conditions; at room temperature or 4C, with or without light-protection, for 6 months had little effects on the amounts of eluted cefazolin. The results showed both in-housed cefazolin-PMMA beads and cefazolin-calcium sulfate beads could be the effective tools for the treatment of local bacterial infections.

The present study aimed to evaluate the pharmacokinetic features of tolfenamic acid (TA) in green sea turtles, Chelonia mydas. Green sea turtles were administered single either intravenous (i.v.) or intramuscular (i.m.) injection of TA, at a dose of 4 mg/kg body weight (b.w.). Blood samples were collected at preassigned times up to 168 hr. The plasma concentrations of TA were measured using a validated liquid chromatography tandem mass spectrometry method. Tolfenamic acid plasma concentrations were quantifiable for up to 168 hr after i.v. and i.m. administration. The concentration of TA in the experimental green sea turtles with respect to time was pharmacokinetically analyzed using a noncompartment model. The Cmax values of TA were 55.01 ± 8.34 µg/ml following i.m. administration. The elimination half‐life values were 32.76 ± 4.68 hr and 53.69 ± 3.38 hr after i.v. and i.m. administration, respectively. The absolute i.m. bioavailability was 72.02 ± 10.23%, and the average binding percentage of TA to plasma protein was 19.43 ± 6.75%. Based on the pharmacokinetic data, the i.m. administration of TA at a dosage of 4 mg/kg b.w. might be sufficient to produce a long‐lasting anti‐inflammatory effect (7 days) for green sea turtles. However, further studies are needed to determine the clinical efficacy of TA for treatment of inflammatory disease after single and multiple dosages.

A significant impact of marine pollution is the contamination of seafood which has raised concerns due to its potential human health risks. This current study investigated seasonal bioaccumulation of 9 heavy metals (Cd, Co, Cr, Cu, Fe, Mn, Ni, Pb, and Zn) in 14 commercially important seafood species, including 4 fish, 5 molluscs, and 5 crustacean species. Samples were collected from Pattani Bay, Pattani province, Thailand, during the dry (July 2020) and wet (February 2021) seasons. The edible samples were analyzed for heavy metal concentrations using a flame atomic absorption spectrophotometer. The bioaccumulation trend of heavy metals decreased in the sequence of molluscs > crustaceans > fish. The possible human health risks associated with heavy metal-contaminated seafood consumption were assessed. The parameters investigated for non-carcinogenic and carcinogenic were target hazard quotient (THQ), total hazard index (HI), and target cancer risk (TR). The average ranges of THQs (7.79 × 10−8–8.97 × 10−3), HIs (4.30 × 10−5–1.55 × 10−2), and TRs (2.70 × 10−9–1.34 × 10−5) were observed in the studied seafood species. The results revealed no non-carcinogenic and carcinogenic health risks from consuming these 14 kinds of seafood.

To the best of the authors’ knowledge, pharmacokinetic information to establish suitable therapeutic plans for freshwater crocodiles is limited. Therefore, the purpose of this study was to clarify the pharmacokinetic characteristics of enrofloxacin (ENR) in freshwater crocodiles, Crocodylus siamensis, following single intravenous and intramuscular administration at a dosage of 5 mg/kg body weight (b.w.). Blood samples were collected at assigned times up to 168 hr. The plasma concentrations of ENR and its metabolite ciprofloxacin (CIP) were measured by liquid chromatography tandem–mass spectrometry. The concentrations of ENR and CIP in the plasma were quantified up to 144 hr after both the administrations. The half‐life was long (43–44 hr) and similar after both administrations. The absolute i.m. bioavailability was 82.65% and the binding percentage of ENR to plasma protein ranged from 9% to 18% with an average of 10.6%. Percentage of CIP (plasma concentrations) was 15.9% and 19.9% after i.v. and i.m. administration, respectively. Based on the pharmacokinetic data, susceptibility break point and PK‐PD indexes, i.m. single administration of ENR at a dosage of 5 mg/kg b.w. might be appropriate for treatment of susceptible bacteria (MIC > 1 μg/mL) in freshwater crocodiles, C. siamensis.

Nowadays, the growth rate of sea turtles is declining as a result of an ecological regime shift that has been underway since the late 1990s and is being exacerbated by cumulative impacts, such as the El Nino Southern Oscillation and increasing sea surface temperature (Bjorndal, 2017). Even anthropogenic factors are playing a primary role in reducing the numbers of sea turtles. Indeed, the primary cause of mortality of sea turtles is spontaneous diseases (26.88%), including distinct types of pneumonia, hepatitis, meningitis, septicemic processes, and neoplasm, but there have also been significant impacts from human activities, such as boat-strike injuries (23.66%),